AVTR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03

Price $15.34

Market Cap $10.46B

P/E (TTM) -18.3

EPS (TTM) $-0.84

Revenue (TTM) $6.56B

ROE (TTM) -9.7%

Debt/Equity (MRQ) 0.7

52W Range $7–$16

AVTR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04

range

bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

About Avantor, Inc. Common Stock Company overview from Wikipedia

05 · wikidata

Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.

History

The company's history traces back to 1904, when John Townsend Baker (1860–1935) founded the chemical company J.T. Baker specializing in producing chemically pure reagents. The company gained recognition for its "Baker Analyzed" labels, which provided detailed analyses of trace impurities in its products. In 1911, the company began publishing "The Chemist-Analyst," which promoted its products and philosophy. After Baker's death in 1935, the company was acquired by Vick Chemical Company in 1941. During World War II, J.T. Baker expanded its product line to include penicillin, pesticides, and chemicals for batteries and munitions. After the war, the company further diversified into high-purity solvents, chromatography columns, and hazardous waste spill kits. In 1985, J.T. Baker and its parent company Richardson-Vicks were sold to Procter & Gamble, and subsequently sold to Mallinckrodt in 1995.

In 2010, investment firm New Mountain Capital purchased Mallinckrodt Baker Inc., which then changed its name to Avantor. The company extended its international market with the 2011 acquisitions of the Indian laboratory reagents supplier RFCL and the Polish lab supply firm POCH.

In 2016, Avantor merged with Nusil Technology. In 2017, Avantor acquired chemical blending business Puritan Products Inc. and laboratory supplies company VWR. The combined company operates under the Avantor name, with VWR and vwr.com remaining as a selling channel.

In May 2019, Avantor went public with a $3.8 billion initial public offering, which gave the company a market capitalization of $7.62 billion. As of December 2023, the top shareholders of Avantor included Vanguard Group Inc., Dodge & Cox Inc., T. Rowe Price Investment Management Inc., and BlackRock Inc.

That same year the company expanded further into Asia with the opening of an innovation center in Shanghai, which focuses on monoclonal antibodies and cell and gene therapy. In 2020, Avantor doubled the size of its Bridgewater, New Jersey innovation center, expanding its research and development capabilities and cell and gene therapy reagent manufacturing.

In 2020, Avantor began providing services and raw materials to companies manufacturing vaccines and other therapies to fight the COVID-19 pandemic. Avantor added employees and extra shifts in order to increase capacity for producing synthetic lipids that are formed into nanoparticles, which carry mRNA into human cells.

In June 2021, Avantor acquired China-based RIM Bio, a manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.

Through the acquisition, Avantor gained access to RIM's Changzhou, China facility, marking Avantor's first single-use production plant in the Africa, Middle East, Asia (AMEA) region. The deal is part of a larger expansion of the company's single-use manufacturing footprint with plans to increase its presence by 30%.

The company ranked 485th in 2023 and 506 in 2024 on the Fortune 500, based on its sales records.

Controversies

On August 26, 2020, Bloomberg News implicated Avantor and other companies in the U.S. opioid epidemic. According to Bloomberg, one of their compounds "acetic anhydride", was used illicitly by drug traffickers to convert crude opium into heroin. Bloomberg also found evidence that Avantor's compound was used in cartel drug labs, and that regulations implemented in 2018 didn't stop it from being widely available. In response, Avantor discontinued all sales of acetic anhydride in Mexico and destroyed its existing inventory. In 2021, Texas Senator John Cornyn, who serves on both the Judiciary Committee and the bipartisan Caucus on International Narcotics Control claims that Avantor should have known better, selling acetic anhydride within Mexico's unregulated market. What should have raised eyebrows as well is that it was sold in 18-liter containers, which is inconsistent with the ordinary use of acetic anhydride. Four other Republican senators also deplored Avantor's “apparent longstanding contribution to the opioid epidemic that killed 50,000 of our fellow citizens in 2019.”

10-Year Performance Revenue, net income, margins and EPS trends

06

Revenue$6.55B

2017-12-31 → 2025-12-31

EPS$-0.78

2018-12-31 → 2025-12-31

Free Cash Flow$495M

2019-12-31 → 2025-12-31

Net margin-8.8%

2019-12-31 → 2025-12-31

Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric	AVTR	5Y avg	Peer Median	Verdict
P/E (TTM)	-18.35Y avg ≈24.9	≈24.9	·	·
P/S	1.65Y avg ≈2.2	≈2.2	3.7	Undervalued
P/B	1.95Y avg ≈3.2	≈3.2	3.6	Undervalued
EV / EBITDA	-57.05Y avg ≈10.3	≈10.3	·	·
Price / FCF	21.15Y avg ≈21.7	≈21.7	·	·
Price / Cash Flow	16.85Y avg ≈18.2	≈18.2	25.2	Undervalued
EV / Revenue	2.15Y avg ≈2.9	≈2.9	·	·
EV / FCF	28.45Y avg ≈28.9	≈28.9	·	·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric	AVTR	5Y avg	Peer Median	Verdict
Gross Margin (TTM)	31.8%5Y avg ≈33.7%	≈33.7%	54.2%	Weak
Operating Margin (TTM)	-4.6%5Y avg ≈10.1%	≈10.1%	9.2%	Below avg
EBITDA Margin	-3.8%5Y avg ≈10.1%	≈10.1%	8.3%	Weak
Pretax Margin (TTM)	-7.2%5Y avg ≈6.7%	≈6.7%	5.9%	Below avg
Net Profit Margin (TTM)	-8.8%5Y avg ≈4.8%	≈4.8%	2.4%	In line
ROA (TTM)	-4.7%5Y avg ≈2.7%	≈2.7%	-0.14%	Weak
ROE (TTM)	-9.7%5Y avg ≈7.6%	≈7.6%	-0.40%	Weak
ROIC	-3.1%5Y avg ≈5.1%	≈5.1%	1.1%	Weak

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric	AVTR	5Y avg	Peer Median	Verdict
Debt / Equity (MRQ)	0.75Y avg ≈1.1	≈1.1	0.7	In line
Current Ratio (MRQ)	1.85Y avg ≈1.6	≈1.6	3.0	Low liquidity
Quick Ratio	1.05Y avg ≈0.9	≈0.9	1.6	Below avg
Long-Term Debt / Equity (MRQ)	0.75Y avg ≈1.0	≈1.0	0.7	In line

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric	AVTR	5Y avg	Peer Median	Verdict
Revenue YoY	-3.4%5Y avg ≈0.78%	≈0.78%	·	·
Revenue CAGR 3Y	-4.5%5Y avg ≈-1.4%	≈-1.4%	·	·
Revenue CAGR 5Y	0.49%	·	·	·
EPS YoY	121.3%5Y avg ≈232.8%	≈232.8%	·	·
Net Income YoY	121.6%5Y avg ≈119.8%	≈119.8%	·	·
EPS CAGR 3Y	7.0%	·	·	·
Net Income CAGR 3Y	7.5%	·	·	·

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric	AVTR	5Y avg	Peer Median	Verdict
EPS (Diluted)	$-0.785Y avg ≈$0.52	≈$0.52	·	·
Revenue / Share	$9.635Y avg ≈$10.64	≈$10.64	·	·
Cash Flow / Share	$0.925Y avg ≈$1.25	≈$1.25	·	·
Cash / Share	$0.545Y avg ≈$0.47	≈$0.47	·	·

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric	AVTR	5Y avg	Peer Median	Verdict
Asset Turnover	0.55Y avg ≈0.6	≈0.6	0.5	In line
Inventory Turnover	5.75Y avg ≈5.7	≈5.7	2.5	Top tier
Receivables Turnover	6.25Y avg ≈6.2	≈6.2	5.7	Top tier
Revenue / Employee	≈$485.3K	·	·	·

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14

Avg Surprise 0.49%

Next Report Oct 27, 2026

Period	Report	EPS Actual	EPS Est	Surprise
June 30, 2026	Jul 30, 2026	$0.21	$0.19	8.6%
March 31, 2026		$0.17	$0.16	6.2%
Dec. 31, 2025		$0.22	$0.22	-0.36%
Sept. 30, 2025		$0.22	$0.23	-4.0%
June 30, 2025		$0.24	$0.25	-5.1%
March 31, 2025		$0.23	$0.24	-2.4%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15

Income Statement 16

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B	$6.39B	$6.04B	$5.86B	$1.25B
Cost of Revenue	$4.41B	$4.50B	$4.60B	$4.91B	$4.88B	$4.31B	$4.12B	$4.04B	$815M
Gross Profit	$2.14B	$2.28B	$2.36B	$2.60B	$2.50B	$2.08B	$1.92B	$1.82B	$433M
SG&A Expense	$1.60B	$1.64B	$1.51B	$1.47B	$1.53B	$1.37B	$1.37B	$1.41B	$450M
Operating Income	$-246M	$1.08B	$696M	$1.13B	$972M	$707M	$552M	$414M	$-210M
Interest Expense	·	·	$285M	$266M	$217M	$308M	$440M	$524M	$201M
Interest Income	$42M	$75M	$65M	$16M	$2M	·	·	·	·
Other Non-op	$-21M	$-1M	$6M	$-800.0K	$11M	$10M	$2M	$-4M	$8M
Pretax Income	$-441M	$854M	$410M	$851M	$753M	$62M	$41M	$-114M	$-460M
Income Tax	$89M	$142M	$89M	$165M	$180M	$-54M	$3M	$-27M	$-315M
Net Income	$-530M	$712M	$321M	$686M	$573M	$117M	$38M	$-87M	$-113M
EPS (Basic)	$-0.78	$1.05	$0.48	$1.02	$0.86	$0.09	$-0.84	$-2.69	·
EPS (Diluted)	$-0.78	$1.04	$0.47	$1.01	$0.85	$0.09	$-0.84	$-2.69	·
Shares (Basic)	680,600,000	679,600,000	675,600,000	650,900,000	590,500,000	576,300,000	401,200,000	132,700,000	·
Shares (Diluted)	680,600,000	681,900,000	678,400,000	679,400,000	599,600,000	583,400,000	401,200,000	132,700,000	·
EBITDA	$-246M	$1.08B	$696M	$1.13B	$972M	$707M	$552M	·	·

Balance Sheet 26

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
Cash & Equivalents	$365M	$262M	$263M	$373M	$302M	$287M	$187M	$185M	·
Receivables	$1.07B	$1.03B	$1.15B	$1.22B	$1.22B	$1.11B	$989M	$931M	·
Inventory	$818M	$732M	$828M	$914M	$872M	$740M	$711M	$671M	·
Other Current Assets	$193M	$119M	$144M	$153M	$81M	$91M	$135M	$113M	·
Current Assets	$2.45B	$2.15B	$2.38B	$2.66B	$2.48B	$2.23B	$2.02B	$1.90B	·
PP&E (Net)	$767M	$708M	$738M	$727M	$706M	$550M	$557M	$599M	·
PP&E (Gross)	$1.51B	$1.34B	$1.35B	$1.25B	$1.15B	$938M	$865M	$824M	·
Accum. Depreciation	$745M	$630M	$617M	$518M	$445M	$388M	$308M	$226M	·
Goodwill	$4.99B	$5.54B	$5.72B	$5.65B	$5.34B	$2.86B	$2.77B	$2.78B	$2.85B
Intangibles	$3.10B	$3.27B	$3.68B	$4.04B	$5.05B	$3.96B	$4.13B	$4.47B	·
Other Non-current Assets	$396M	$360M	$358M	$294M	$233M	$217M	$205M	$63M	·
Total Assets	$11.79B	$12.11B	$12.97B	$13.46B	$13.90B	$9.91B	$9.77B	$9.91B	·
Accounts Payable	$742M	$663M	$626M	$758M	$755M	$679M	$560M	$557M	·
Current Liabilities	$1.38B	$2.01B	$1.48B	$1.66B	$1.45B	$1.24B	$1.07B	$1.10B	·
Capital Leases	$152M	$143M	$88M	$87M	$79M	·	$107M	·	·
Deferred Tax	$557M	$557M	$613M	$731M	$913M	$724M	$785M	$908M	·
Other Non-current Liabilities	$378M	$358M	$350M	$295M	$358M	$398M	$428M	$318M	·
Total Liabilities	$6.23B	$6.16B	$7.72B	$8.61B	$9.70B	$7.23B	$7.31B	$9.10B	·
Long-term Debt	$3.95B	$4.06B	$5.54B	$6.29B	$7.02B	$4.89B	$5.12B	$6.92B	·
Total Debt	$3.95B	$4.06B	$5.54B	$6.29B	$7.02B	$4.89B	$5.12B	·	·
Retained Earnings	$1.67B	$2.20B	$1.49B	$1.17B	$484M	$-89M	$-204M	$-238M	·
Treasury Stock	$76M	$0	·	·	·	·	·	·	·
AOCI	$-17M	$-184M	$-69M	$-100M	$-43M	$22M	$-86M	$-66M	$26M
Stockholders' Equity	$5.57B	$5.96B	$5.25B	$4.86B	$4.20B	$2.67B	$2.46B	$-3.05B	$-2.62B
Liabilities + Equity	$11.79B	$12.11B	$12.97B	$13.46B	$13.90B	$9.91B	$9.77B	$9.91B	·
Shares Outstanding	682,000,000	680,800,000	676,600,000	674,300,000	609,700,000	580,100,000	572,800,000	132,800,000	·

Cash Flow 18

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
D&A	$410M	$406M	$402M	$406M	$379M	$395M	$399M	$405M	$99M
Stock-based Comp	$46M	$47M	$40M	$46M	$51M	$44M	$68M	$18M	$48M
Deferred Tax	$8M	$-47M	$-172M	$-69M	$-18M	$-88M	$-107M	$-104M	$-431M
Amort. of Intangibles	$301M	$300M	$308M	$318M	$291M	$308M	$312M	$321M	$65M
Restructuring	$30M	$83M	$26M	$4M	$5M	$12M	$24M	$81M	$30M
Operating Cash Flow	$624M	$841M	$870M	$844M	$954M	$930M	$354M	$200M	$-168M
CapEx	$129M	$149M	$146M	$133M	$111M	$62M	$52M	$38M	$25M
Investing Cash Flow	$-130M	$439M	$-144M	$-110M	$-4.12B	$-59M	$-42M	$-23M	$-6.68B
Debt Issued	$1.11B	$0	$0	$327M	$2.83B	$3.94B	$1M	$36M	$9.25B
Net Debt Issued	$-319M	$-1.34B	$-846M	$-620M	$2.30B	$-423M	$-1.88B	·	·
Stock Issued	·	·	$0	$0	$967M	$0	$4.24B	·	·
Stock Repurchased	$75M	$0	$0	·	·	·	·	·	·
Net Stock Activity	$-75M	·	$0	$0	$967M	·	·	·	·
Financing Cash Flow	$-409M	$-1.28B	$-844M	$-649M	$3.22B	$-783M	$-308M	$-170M	$6.96B
Net Change in Cash	$104M	$-23M	$-109M	$70M	$38M	$100M	$2M	$-800.0K	$122M
Taxes Paid	$145M	$248M	$224M	$257M	$145M	$43M	$112M	$66M	$32M
Free Cash Flow	$495M	$692M	$724M	$710M	$842M	$868M	$302M	·	·
Levered FCF	·	·	$501M	$496M	$677M	$292M	$-107M	·	·

Profitability 8

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
Gross Margin	32.6%	33.6%	33.9%	34.6%	33.9%	32.5%	31.8%	·	·
Operating Margin	-3.8%	16.0%	10.0%	15.0%	13.2%	11.1%	9.1%	·	·
Net Margin	-8.1%	10.5%	4.6%	9.1%	7.8%	1.8%	0.63%	·	·
Pretax Margin	-6.7%	12.6%	5.9%	11.3%	10.2%	0.97%	0.67%	·	·
EBITDA Margin	-3.8%	16.0%	10.0%	15.0%	13.2%	11.1%	9.1%	·	·
ROA	-4.4%	5.7%	2.4%	5.0%	4.8%	1.2%	0.38%	·	·
ROE	-8.9%	12.4%	6.2%	14.5%	13.8%	4.5%	1.6%	·	·
ROIC	-3.1%	9.0%	5.1%	8.2%	6.6%	17.5%	6.8%	·	·

Liquidity & Solvency 5

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
Current Ratio	1.8	1.1	1.6	1.6	1.7	1.8	1.9	·	·
Quick Ratio	1.0	0.6	1.0	1.0	1.1	1.1	1.1	·	·
Debt / Equity	0.7	0.7	1.1	1.3	1.7	1.8	2.1	·	·
LT Debt / Equity	0.7	0.5	1.0	1.2	1.7	1.8	2.0	·	·
Interest Coverage	·	·	2.4	4.3	4.5	2.3	1.3	·	·

Efficiency 3

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
Asset Turnover	0.5	0.5	0.5	0.5	0.6	0.6	0.6	·	·
Inventory Turnover	5.7	5.8	5.3	5.5	6.1	5.9	6.0	·	·
Receivables Turnover	6.2	6.2	5.9	6.2	6.3	6.1	6.3	·	·

Per Share 5

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
Book Value / Share	$8.16	$8.75	$7.76	$7.20	$6.88	$4.61	$4.30	·	·
Revenue / Share	$9.63	$9.95	$10.27	$11.06	$12.32	$10.96	·	·	·
Cash Flow / Share	$0.92	$1.23	$1.28	$1.24	$1.59	$1.59	·	·	·
Cash / Share	$0.54	$0.38	$0.39	$0.55	$0.49	$0.49	$0.33	·	·
EPS (TTM)	$-0.78	$1.04	$0.47	$1.01	$0.85	$0.09	$-0.84	·	·

Growth Rates 7

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue YoY	-3.4%	-2.6%	-7.3%	1.7%	15.5%	·	·	·	·
Revenue CAGR 3Y	-4.5%	-2.8%	2.9%	·	·	·	·	·	·
Revenue CAGR 5Y	0.49%	·	·	·	·	·	·	·	·
EPS YoY	·	121.3%	-53.5%	18.8%	844.4%	·	·	·	·
EPS CAGR 3Y	·	7.0%	73.5%	·	·	·	·	·	·
Net Income YoY	·	121.6%	-53.2%	19.9%	391.1%	·	·	·	·
Net Income CAGR 3Y	·	7.5%	40.2%	·	·	·	·	·	·

Valuation (TTM) 13

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017
Revenue TTM	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B	$6.39B	$6.04B	·	·
Net Income TTM	$-530M	$712M	$321M	$686M	$573M	$117M	$38M	·	·
Market Cap	$7.82B	$14.34B	$15.45B	$14.22B	$25.69B	$16.33B	$10.40B	·	·
Enterprise Value	$11.40B	$18.14B	$20.72B	$20.14B	$32.41B	$20.94B	$15.33B	·	·
P/E	-14.7	20.3	48.6	20.9	49.6	312.8	-21.6	·	·
P/S	1.2	2.1	2.2	1.9	3.5	2.6	1.7	·	·
P/B	1.4	2.4	2.9	2.9	6.1	6.1	4.2	·	·
P / Cash Flow	12.5	17.1	17.8	16.9	26.9	17.6	29.4	·	·
P / FCF	15.8	20.7	21.3	20.0	30.5	18.8	34.4	·	·
EV / EBITDA	-46.3	16.7	29.8	17.8	33.3	29.6	27.8	·	·
EV / FCF	23.0	26.2	28.6	28.4	38.5	24.1	50.7	·	·
EV / Revenue	1.7	2.7	3.0	2.7	4.4	3.3	2.5	·	·
Earnings Yield	-6.8%	4.9%	2.1%	4.8%	2.0%	0.32%	-4.6%	·	·

Income Statement 16

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$1.69B	$1.58B	$1.66B	$1.62B	$1.68B	$1.58B	$1.69B	$1.71B	$1.70B	$1.68B	$1.72B	$1.72B	$1.74B	$1.78B	$1.79B	$1.86B
Cost of Revenue	$1.16B	$1.08B	$1.14B	$1.10B	$1.13B	$1.05B	$1.12B	$1.15B	$1.12B	$1.11B	$1.15B	$1.14B	$1.15B	$1.16B	$1.18B	$1.21B
Gross Profit	$537M	$501M	$524M	$526M	$554M	$535M	$563M	$564M	$582M	$570M	$570M	$579M	$590M	$625M	$614M	$651M
SG&A Expense	$415M	$401M	$392M	$390M	$425M	$388M	$371M	$440M	$406M	$424M	$387M	$368M	$358M	$394M	$363M	$375M
Operating Income	$122M	$100M	$126M	$-649M	$129M	$147M	$638M	$125M	$176M	$146M	$183M	$210M	$72M	$231M	$252M	$276M
Interest Expense	$39M	$43M	·	$44M	$43M	$42M	·	$49M	$61M	$64M	·	$72M	$73M	$74M	·	$67M
Interest Income	$10M	$10M	$11M	$12M	$11M	$8M	$12M	$27M	$18M	$18M	$18M	$17M	$16M	$14M	·	·
Other Non-op	$-600.0K	$-500.0K	$-1M	$4M	$-4M	$-20M	$-5M	$700.0K	$2M	$1M	$2M	$700.0K	$2M	$600.0K	$-6M	$3M
Pretax Income	$81M	$56M	$81M	$-690M	$82M	$86M	$584M	$74M	$115M	$81M	$120M	$136M	$-1M	$156M	$175M	$208M
Income Tax	$43M	$12M	$28M	$22M	$17M	$21M	$84M	$17M	$22M	$20M	$21M	$28M	$6M	$34M	$33M	$41M
Net Income	$38M	$43M	$52M	$-712M	$65M	$64M	$500M	$58M	$93M	$60M	$98M	$108M	$-7M	$122M	$142M	$167M
EPS (Basic)	$0.06	$0.06	$0.08	$-1.04	$0.09	$0.09	$0.74	$0.08	$0.14	$0.09	$0.15	$0.16	$-0.01	$0.18	$0.20	$0.25
EPS (Diluted)	$0.06	$0.06	$0.08	$-1.04	$0.09	$0.09	$0.73	$0.08	$0.14	$0.09	$0.14	$0.16	$-0.01	$0.18	$0.20	$0.25
Shares (Basic)	676,200,000	675,700,000	·	681,700,000	681,500,000	681,100,000	·	680,300,000	679,400,000	678,100,000	·	676,000,000	675,300,000	674,700,000	·	674,100,000
Shares (Diluted)	677,200,000	676,800,000	·	681,700,000	681,800,000	682,400,000	·	683,000,000	682,600,000	681,400,000	·	678,500,000	675,300,000	678,100,000	·	679,300,000
EBITDA	$122M	$100M	·	$-649M	$129M	$147M	·	$125M	$176M	$146M	·	$210M	$72M	$231M	·	$276M

Balance Sheet 26

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$307M	$279M	$365M	$252M	$449M	$316M	$262M	$285M	$273M	$235M	·	$237M	$236M	$295M	·	$266M
Receivables	$1.14B	$1.10B	$1.07B	$1.08B	$1.15B	$1.10B	$1.03B	$1.09B	$1.13B	$1.13B	·	$1.15B	$1.22B	$1.28B	·	$1.23B
Inventory	$829M	$810M	$818M	$796M	$780M	$750M	$732M	$780M	$796M	$811M	·	$850M	$890M	$904M	·	$905M
Other Current Assets	$188M	$210M	$193M	$132M	$136M	$120M	$119M	$136M	$132M	$146M	·	$147M	$156M	$152M	·	$158M
Current Assets	$2.46B	$2.40B	$2.45B	$2.26B	$2.51B	$2.28B	$2.15B	$2.50B	$2.33B	$2.32B	·	$2.38B	$2.50B	$2.63B	·	$2.56B
PP&E (Net)	$772M	$766M	$767M	$762M	$759M	$736M	$708M	$723M	$754M	$740M	·	$698M	$698M	$736M	·	$698M
PP&E (Gross)	·	·	$1.51B	·	·	·	$1.34B	·	·	·	·	·	·	·	·	·
Accum. Depreciation	$787M	$766M	$745M	$724M	$700M	$663M	$630M	$621M	$657M	$635M	·	$580M	$565M	$541M	·	$489M
Goodwill	$4.94B	$4.95B	$4.99B	$4.98B	$5.76B	$5.61B	$5.54B	$5.67B	$5.66B	$5.67B	$5.72B	$5.64B	$5.69B	$5.68B	$5.65B	$5.51B
Intangibles	$2.92B	$3.01B	$3.10B	$3.17B	$3.26B	$3.24B	$3.27B	$3.43B	$3.49B	$3.57B	·	$3.70B	$3.80B	$3.98B	·	$4.01B
Other Non-current Assets	$412M	$442M	$396M	$406M	$391M	$368M	$360M	$420M	$368M	$368M	·	$289M	$277M	$272M	·	$245M
Total Assets	$11.60B	$11.66B	$11.79B	$11.68B	$12.78B	$12.33B	$12.11B	$12.84B	$12.69B	$12.76B	·	$12.80B	$13.06B	$13.40B	·	$13.11B
Accounts Payable	$743M	$736M	$742M	$692M	$709M	$680M	$663M	$674M	$657M	$573M	·	$656M	$687M	$766M	·	$769M
Current Liabilities	$1.38B	$1.37B	$1.38B	$1.52B	$2.58B	$2.03B	$2.01B	$1.63B	$1.46B	$1.44B	·	$1.49B	$1.55B	$1.67B	·	$1.55B
Capital Leases	·	·	$152M	·	·	·	$143M	·	·	·	·	·	·	·	·	·
Deferred Tax	$540M	$550M	$557M	$548M	$536M	$550M	$557M	$547M	$575M	$601M	·	$649M	$663M	$696M	·	$728M
Other Non-current Liabilities	$383M	$377M	$378M	$403M	$391M	$365M	$358M	$419M	$362M	$361M	·	$271M	$269M	$300M	·	$334M
Total Liabilities	$5.97B	$6.07B	$6.23B	$6.11B	$6.49B	$6.23B	$6.16B	$7.29B	$7.26B	$7.43B	·	$7.70B	$8.05B	$8.40B	·	$8.52B
Long-term Debt	$3.70B	$3.82B	$3.95B	$3.86B	$4.24B	$4.11B	$4.06B	$4.92B	$5.12B	$5.32B	·	$5.63B	$5.88B	$6.06B	·	$6.19B
Total Debt	$3.70B	$3.82B	·	$3.86B	$4.24B	$4.11B	·	$4.92B	$5.12B	$5.32B	·	$5.63B	$5.88B	$6.06B	·	$6.19B
Retained Earnings	$1.75B	$1.72B	$1.67B	$1.62B	$2.33B	$2.27B	$2.20B	$1.70B	$1.64B	$1.55B	·	$1.39B	$1.28B	$1.29B	·	$1.03B
Treasury Stock	$76M	$76M	$76M	·	·	·	$0	·	·	·	·	·	·	·	·	·
AOCI	$-55M	$-44M	$-17M	$-24M	$-10M	$-118M	$-184M	$-74M	$-107M	$-97M	·	$-111M	$-72M	$-90M	$-100M	$-212M
Stockholders' Equity	$5.63B	$5.59B	$5.57B	$5.57B	$6.29B	$6.10B	$5.96B	$5.55B	$5.43B	$5.34B	$5.25B	$5.10B	$5.01B	$4.99B	$4.86B	$4.59B
Liabilities + Equity	$11.60B	$11.66B	$11.79B	$11.68B	$12.78B	$12.33B	$12.11B	$12.84B	$12.69B	$12.76B	·	$12.80B	$13.06B	$13.40B	·	$13.11B
Shares Outstanding	·	682,900,000	682,000,000	681,900,000	681,600,000	681,500,000	680,800,000	680,600,000	679,600,000	679,200,000	·	676,300,000	675,700,000	675,100,000	·	674,200,000

Cash Flow 14

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$106M	$105M	$103M	$104M	$103M	$100M	$101M	$102M	$103M	$100M	$101M	$98M	$103M	$101M	$101M	$101M
Stock-based Comp	$15M	$9M	$11M	$7M	$16M	$12M	$11M	$12M	$11M	$13M	$9M	$10M	$9M	$13M	$10M	$12M
Deferred Tax	$16M	$-10M	$50M	$-12M	$-18M	$-12M	$28M	$-23M	$-35M	$-18M	$-78M	$-29M	$-38M	$-26M	$-7M	$-22M
Restructuring	·	·	$2M	$2M	·	·	$500.0K	$49M	·	·	$8M	$6M	$7M	$5M	$-200.0K	$1M
Operating Cash Flow	$178M	$59M	$153M	$207M	$154M	$109M	$173M	$245M	$281M	$142M	$252M	$231M	$168M	$220M	$206M	$258M
CapEx	$38M	$34M	$36M	$36M	$30M	$28M	$28M	$41M	$46M	$35M	$51M	$38M	$30M	$28M	$34M	$39M
Investing Cash Flow	$-37M	$-33M	$-40M	$-33M	$-29M	$-29M	$558M	$-40M	$-45M	$-34M	$-50M	$-37M	$-29M	$-27M	$-33M	$4M
Debt Issued	·	·	$1.04B	$68M	$0	$0	$0	$-12M	$-29M	$41M	$0	$0	$0	$0	$82M	$35M
Net Debt Issued	·	$-105M	·	·	·	$-31M	·	·	·	$-169M	·	·	·	$-270M	·	·
Financing Cash Flow	$-112M	$-107M	$700.0K	$-370M	$-7M	$-34M	$-755M	$-199M	$-197M	$-130M	$-184M	$-188M	$-196M	$-275M	$-82M	$-219M
Net Change in Cash	$28M	$-86M	$114M	$-198M	$134M	$54M	$-46M	$14M	$38M	$-28M	$27M	$-100.0K	$-58M	$-78M	$109M	$27M
Taxes Paid	$30M	$10M	$29M	$22M	$77M	$17M	$120M	$42M	$69M	$17M	$29M	$69M	$113M	$14M	$75M	$51M
Free Cash Flow	·	$25M	·	·	·	$81M	·	·	·	$107M	·	·	·	$192M	·	·
Levered FCF	·	$-8M	·	·	·	$50M	·	·	·	$59M	·	·	·	$134M	·	·

Profitability 8

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	31.7%	31.7%	·	32.4%	32.9%	33.8%	·	32.9%	34.2%	34.0%	·	33.6%	33.8%	35.1%	·	35.0%
Operating Margin	7.2%	6.3%	·	-40.0%	7.6%	9.3%	·	7.3%	10.3%	8.7%	·	12.2%	4.1%	13.0%	·	14.9%
Net Margin	2.2%	2.7%	·	-43.8%	3.8%	4.1%	·	3.4%	5.5%	3.6%	·	6.3%	-0.42%	6.8%	·	9.0%
Pretax Margin	4.8%	3.5%	·	-42.5%	4.9%	5.4%	·	4.3%	6.7%	4.8%	·	7.9%	-0.07%	8.8%	·	11.2%
EBITDA Margin	7.2%	6.3%	·	-40.0%	7.6%	9.3%	·	7.3%	10.3%	8.7%	·	12.2%	4.1%	13.0%	·	14.9%
ROA	0.31%	0.36%	·	-5.8%	0.51%	0.51%	·	0.45%	0.72%	0.46%	·	0.84%	-0.06%	0.89%	·	1.3%
ROE	0.64%	0.74%	·	-12.8%	1.1%	1.1%	·	1.1%	1.8%	1.2%	·	2.2%	-0.15%	2.6%	·	3.8%
ROIC	0.61%	0.83%	·	-7.1%	0.97%	1.1%	·	0.92%	1.4%	1.0%	·	1.6%	3.7%	1.6%	·	2.1%

Liquidity & Solvency 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	1.8	1.8	·	1.5	1.0	1.1	·	1.5	1.6	1.6	·	1.6	1.6	1.6	·	1.6
Quick Ratio	1.0	1.0	·	0.9	0.6	0.7	·	0.8	1.0	0.9	·	0.9	0.9	0.9	·	1.0
Debt / Equity	0.7	0.7	·	0.7	0.7	0.7	·	0.9	0.9	1.0	·	1.1	1.2	1.2	·	1.3
LT Debt / Equity	0.7	0.7	·	0.7	0.5	0.5	·	0.8	0.9	0.9	·	1.0	1.1	1.1	·	1.3
Interest Coverage	3.1	2.3	·	-14.7	3.0	3.5	·	2.6	2.9	2.3	·	2.9	1.0	3.1	·	4.1

Efficiency 3

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	1.4	1.4	·	1.4	1.4	1.3	·	1.4	1.3	1.3	·	1.3	1.3	1.3	·	1.4
Receivables Turnover	1.5	1.4	·	1.5	1.5	1.4	·	1.5	1.5	1.4	·	1.4	1.4	1.4	·	1.5

Per Share 5

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	·	$8.18	·	$8.17	$9.22	$8.95	·	$8.16	$8.00	$7.86	·	$7.54	$7.42	$7.40	·	$6.81
Revenue / Share	$2.50	$2.34	·	$2.38	$2.47	$2.32	·	$2.51	$2.49	$2.47	·	$2.54	$2.58	$2.63	·	$2.73
Cash Flow / Share	·	$0.09	·	·	·	$0.16	·	·	·	$0.21	·	·	·	$0.32	·	·
Cash / Share	·	$0.41	·	$0.37	$0.66	$0.46	·	$0.42	$0.40	$0.35	·	$0.35	$0.35	$0.44	·	$0.39
EPS (TTM)	$-0.84	$-0.81	·	$-0.13	$0.99	$1.04	·	$0.45	$0.53	$0.38	·	$0.53	$0.62	$0.91	·	$0.93

Valuation (TTM) 10

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$6.56B	$6.55B	·	$6.58B	$6.67B	$6.69B	·	$6.82B	$6.83B	$6.87B	·	$7.04B	$7.18B	$7.34B	·	$7.62B
Net Income TTM	$-578M	$-551M	·	$-82M	$687M	$716M	·	$310M	$360M	$260M	·	$364M	$423M	$618M	·	$639M
Market Cap	·	$5.35B	·	$8.51B	$9.17B	$11.05B	·	$17.61B	$14.41B	$17.37B	·	$14.26B	$13.88B	$14.27B	·	$13.21B
Enterprise Value	·	$8.89B	·	$12.12B	$12.97B	$14.84B	·	$22.24B	$19.25B	$22.46B	·	$19.65B	$19.53B	$20.04B	·	$19.14B
P/E	-11.8	-9.7	·	-96.0	13.6	15.6	·	57.5	40.0	67.3	·	39.8	33.1	23.2	·	21.1
P/S	·	0.8	·	1.3	1.4	1.7	·	2.6	2.1	2.5	·	2.0	1.9	1.9	·	1.7
P/B	·	1.0	·	1.5	1.5	1.8	·	3.2	2.7	3.3	·	2.8	2.8	2.9	·	2.9
P / Cash Flow	·	91.2	·	·	·	101.1	·	·	·	122.6	·	·	·	65.0	·	·
EV / Revenue	·	1.4	·	1.8	1.9	2.2	·	3.3	2.8	3.3	·	2.8	2.7	2.7	·	2.5
Earnings Yield	-8.5%	-10.3%	·	-1.0%	7.4%	6.4%	·	1.7%	2.5%	1.5%	·	2.5%	3.0%	4.3%	·	4.7%

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$6.55B	$6.78B	$6.97B	$7.51B	$7.39B
Gross Margin %	32.6%	33.6%	33.9%	34.6%	33.9%
Operating Margin %	-3.8%	16.0%	10.0%	15.0%	13.2%
Net Income	$-530M	$712M	$321M	$686M	$573M
Diluted EPS	$-0.78	$1.04	$0.47	$1.01	$0.85

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Debt / Equity	0.7	0.7	1.1	1.3	1.7
Current Ratio	1.8	1.1	1.6	1.6	1.7
Quick Ratio	1.0	0.6	1.0	1.0	1.1

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Free Cash Flow	$495M	$692M	$724M	$710M	$842M

Institutional owners (13F) 493 filers · $7.6B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 493

Value held $7.6B

New positions 97

Exited positions 60

Institutional activity — Q2 2026 vs prior quarter

New positions	Exited positions	Increased	Decreased	Net shares change
97 (-7 vs prior Q)	60 (-11 vs prior Q)	192 (+31 vs prior Q)	113 (-15 vs prior Q)	+24.9M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution	Value	Shares	% of tracked 13F	Type
Dodge & Cox	$1,188,207,643	120,020,974	15.59%	Shares
VANGUARD GROUP INC	$743,810,028	64,904,889	9.76%	Shares
BlackRock, Inc.	$695,784,194	70,281,231	9.13%	Shares
VANGUARD PORTFOLIO MANAGEMENT LLC	$310,298,175	31,343,250	4.07%	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$304,948,067	30,802,835	4.00%	Shares
GREENHAVEN ASSOCIATES INC	$243,909,369	24,637,310	3.20%	Shares
STATE STREET CORP	$213,572,443	21,572,974	2.80%	Shares
DIMENSIONAL FUND ADVISORS LP	$202,086,268	20,412,181	2.65%	Shares
Engine Capital Management, LP	$196,622,217	19,860,830	2.58%	Shares
BARROW HANLEY MEWHINNEY & STRAUSS LLC	$195,386,083	19,735,968	2.56%	Shares
New Mountain Capital, L.L.C.	$138,600,000	14,000,000	1.82%	Shares
Invesco Ltd.	$137,465,065	13,885,360	1.80%	Shares
GEODE CAPITAL MANAGEMENT, LLC	$130,519,321	13,180,567	1.71%	Shares
MARSHALL WACE, LLP	$129,988,565	13,130,158	1.71%	Shares
AQR CAPITAL MANAGEMENT LLC	$115,112,902	11,627,566	1.51%	Shares
BANK OF AMERICA CORP /DE/	$108,794,506	10,989,344	1.43%	Shares
EARNEST PARTNERS LLC	$106,410,397	10,748,525	1.40%	Shares
LONDON CO OF VIRGINIA	$103,811,008	10,485,960	1.36%	Shares
FULLER & THALER ASSET MANAGEMENT, INC.	$101,537,816	10,256,345	1.33%	Shares
D. E. Shaw & Co., Inc.	$94,758,077	9,571,523	1.24%	Shares
First Pacific Advisors, LP	$81,088,326	8,190,740	1.06%	Shares
SEI INVESTMENTS CO	$78,677,367	7,947,198	1.03%	Shares
FMR LLC	$77,670,074	7,845,462	1.02%	Shares
GENDELL JEFFREY L	$75,311,973	7,607,270	0.99%	Shares
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.	$73,188,967	7,392,825	0.96%	Shares
Clarkston Capital Partners, LLC	$67,214,209	6,789,314	0.88%	Shares
MORGAN STANLEY	$66,905,804	6,758,161	0.88%	Shares
GOLDMAN SACHS GROUP INC	$61,422,976	6,204,341	0.81%	Shares
NORGES BANK	$60,307,949	6,091,712	0.79%	Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$57,627,950	5,821,005	0.76%	Shares
NORTHERN TRUST CORP	$56,753,512	5,732,678	0.74%	Shares
Freestone Grove Partners LP	$56,577,352	5,714,884	0.74%	Shares
UBS Group AG	$56,155,742	5,672,297	0.74%	Shares
AMERIPRISE FINANCIAL INC	$54,696,928	5,524,942	0.72%	Shares
YACKTMAN ASSET MANAGEMENT LP	$47,223,000	4,770,000	0.62%	Shares
SOUTHEASTERN ASSET MANAGEMENT INC/TN/	$46,782,232	4,725,478	0.61%	Shares
Brickwood Asset Management LLP	$45,515,438	4,597,519	0.60%	Shares
VANGUARD FIDUCIARY TRUST CO	$42,790,226	4,322,245	0.56%	Shares
JONES FINANCIAL COMPANIES LLLP	$42,363,659	4,120,981	0.56%	Shares
Bank of New York Mellon Corp	$40,800,098	4,121,222	0.54%	Shares
ROYCE & ASSOCIATES LP	$36,393,232	3,676,084	0.48%	Shares
FRONTIER CAPITAL MANAGEMENT CO LLC	$34,719,001	3,506,970	0.46%	Shares
PRIVATE MANAGEMENT GROUP INC	$30,662,617	3,097,234	0.40%	Shares
Voss Capital, LP	$26,235,000	2,650,000	0.34%	Shares
Prescott General Partners LLC	$25,740,000	2,600,000	0.34%	Shares
Gotham Asset Management, LLC	$24,912,796	2,516,444	0.33%	Shares
Quantinno Capital Management LP	$24,177,175	2,442,138	0.32%	Shares
KINNEY ASSET MANAGEMENT, LLC	$23,025,600	1,845,000	0.30%	Shares
Loews Corp	$21,780,000	2,200,000	0.29%	Shares
Western Standard LLC	$20,888,842	2,109,984	0.27%	Shares

Show all 493 institutional owners →

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer	Filed	Stake	Status	Purpose	Filing
The Goldman Sachs Group, Inc., Goldman Sachs & Co. LLC, Broad Street Principal Investments, L.L.C., Bridge Street Opportunity Advisors, L.L.C., StoneBridge 2017, L.P., StoneBridge 2017 Offshore, L.P., StoneBridge 2018, L.P., StoneBridge 2018 Offshore, L.P., VWR Partners, L.P. ×8 filings	May 7, 2021	·	Initial filing	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 47 insiders · 29 officers · 20 directors

19

Insider	Role	Last activity	Shares owned	Buys 12m	Net 12m
Emmanuel Ligner	President and CEO	Aug. 18, 2026 F	737,334	1	$993,125
Michael Stubblefield	President & CEO	May 21, 2025 G	545,500	0	$0
Todd W. Garner	EVP and CFO	Sept. 21, 2026 A	49,688	0	$0
Brent R. Jones	EVP, Chief Financial Officer	Feb. 23, 2026 F	419,782	0	$0
Thomas A Szlosek	EVP & CFO	May 17, 2023 F	77,489	0	$0
Corey Walker	President, VWR Dist. & Servs.	June 21, 2026 F	384,535	0	$0
Mary Blenn	EVP, Chief Operating Officer	Feb. 19, 2026 A	253,384	0	$0
Bjorn Hofman	EVP and COO	May 21, 2019 A	157,143	0	$0
Brittany Hankamer	EVP, Chief HR Officer	Aug. 14, 2026 F	248,864	0	$0
Steven W Eck	SVP & Chief Accounting Officer	July 31, 2026 F	129,593	0	$0
Claudius Sokenu	EVP, Chief Legal & Compliance	July 24, 2026 F	251,228	0	$0
Ludovic Brellier	EVP, Bioscience & Medtech	May 1, 2026 A	146,566	0	$0
Benoit Gourdier	EVP, Bioscience & Medtech	Feb. 23, 2026 F	362,859	0	$0
Christophe Couturier	EVP, AMEA	Aug. 8, 2025 A	211,271	0	$0
James Bramwell	EVP Sales, Customer Excellence	Feb. 27, 2025 S	86,605	0	$0
Kitty Sahin	EVP, Strategy&Corp Development	July 18, 2024 F	42,274	0	$0
Randy Lee Stone	EVP, Laboratory Solutions	April 16, 2024 F	68,105	0	$0
Sheri Lewis	EVP, Global Ops & Supply Chain	Dec. 31, 2023 F	70,692	0	$0
Frederic Vanderhaegen	EVP, Americas and Europe	Aug. 25, 2023 S	160,735	0	$0
Justin Miller	EVP & General Counsel	May 17, 2023 F	93,336	0	$0
Gerard Brophy	EVP, Biopharma Production	May 17, 2023 F	89,032	0	$0
Meghan Henson	EVP, Chief HR Officer	Feb. 24, 2023 A	40,184	0	$0
Michael Wondrasch	EVP & CIO	Feb. 20, 2023 F	96,072	0	$0
Mark Christopher Murray	EVP, Biomaterials & AT	Jan. 13, 2022 F	18,680	0	$0
Devashish Ohri	EVP, IMEA	May 27, 2021 M	139,095	0	$0
Sven Henrichwark	EVP, APAC Region	Feb. 25, 2021 A	19,802	0	$0
Eric Mcallister	EVP, CHRO	May 17, 2020 F	197,899	0	$0
Tanya Foxe	EVP, Operations & Supply Chain	Feb. 21, 2020 A	39,458	0	$0
Ashish Kulkarni	EVP and Chief Technology Officer	May 21, 2019 A	128,571	0	$0
Gregory T Lucier	Director	May 8, 2026 P	60,000	2	$541,200
Simon Dingemans	Director	May 7, 2026 A	31,495	1	$203,500
Louise Makin	Director	May 7, 2026 A	47,140	0	$0
Mala Murthy	Director	May 7, 2026 A	69,479	0	$0
Michael Severino	Director	May 7, 2026 A	85,821	0	$0
Joseph R Massaro	Director	May 7, 2026 A	77,408	0	$0
Gregory L Summe	Director	May 7, 2026 A	83,381	2	$2,065,000
Sanjeev K Mehra	Director	May 7, 2026 A	33,376	2	$4,882,750
John Carethers	Director	May 8, 2025 A	45,858	0	$0
Lan Kang	Director	May 8, 2025 A	52,315	0	$0
Juan Andres	Director	May 8, 2025 A	65,480	0	$0
Jonathan M Peacock	Director	May 8, 2025 A	219,815	0	$0
Christi Shaw	Director	May 11, 2023 A	36,271	0	$0
Matthew S. Holt	Director	May 12, 2022 A	7,908	0	$0
Rajiv Gupta	Director	April 1, 2022 A	780,562	0	$0
Jo Natauri	Director	July 12, 2021 P	557,656	0	$0
Rakesh Sachdev	Director	Feb. 25, 2021 A	32,841	0	$0
Thomas Connolly	Director	June 18, 2020 S	72,620,082	0	$0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 56 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund	Weight	Units	As of	Source
LSEQ · Harbor ETF Trust	2.52%	27,960 NS	July 31, 2026	N-PORT
EPSB · Harbor ETF Trust	1.77%	6,133 NS	July 31, 2026	N-PORT
BSJS · Invesco Exchange-Traded Self-Indexe…	1.51%	11,851,000	Oct. 2, 2026	Daily
DFSV · Dimensional ETF Trust	0.52%	3,118,943 NS	July 31, 2026	N-PORT
BKSE · BNY Mellon ETF Trust	0.40%	25,471 NS	July 31, 2026	N-PORT
IVOV · VANGUARD ADMIRAL FUNDS	0.39%	586,296 SH	Aug. 19, 2026	Daily
QVMM · Invesco Exchange-Traded Fund Trust …	0.32%	88,836 SH	Oct. 2, 2026	Daily
RWK · Invesco Exchange-Traded Fund Trust …	0.27%	230,747 SH	Oct. 2, 2026	Daily
VFVA · VANGUARD WELLINGTON FUND	0.27%	233,604 SH	Aug. 19, 2026	Daily
PTMC · Pacer Funds Trust	0.27%	75,616 NS	July 31, 2026	N-PORT
NUSC · Nushares ETF Trust	0.20%	188,520 NS	July 31, 2026	N-PORT
MIDU · Direxion Shares ETF Trust	0.20%	10,027 NS	July 31, 2026	N-PORT
ESML · iShares Trust	0.20%	376,218 SH	Sept. 11, 2026	Daily
BBMC · J.P. Morgan Exchange-Traded Fund Tr…	0.19%	286,321 NS	July 31, 2026	N-PORT
IVOO · VANGUARD ADMIRAL FUNDS	0.19%	1,104,592 SH	Aug. 19, 2026	Daily
DFAT · Dimensional ETF Trust	0.17%	1,765,932 NS	July 31, 2026	N-PORT
DFAS · Dimensional ETF Trust	0.17%	1,854,609 NS	July 31, 2026	N-PORT
IYH · iShares Trust	0.16%	386,410 SH	Sept. 11, 2026	Daily
VBR · VANGUARD INDEX FUNDS	0.14%	9,920,672 SH	Aug. 19, 2026	Daily
SMMD · iShares Trust	0.14%	351,599 SH	Sept. 11, 2026	Daily
FHLC · FIDELITY COVINGTON TRUST	0.13%	313,238 NS	July 31, 2026	N-PORT
REVS · Columbia ETF Trust I	0.12%	28,653 NS	July 31, 2026	N-PORT
VHT · VANGUARD WORLD FUND	0.10%	1,983,361 SH	Aug. 19, 2026	Daily
IWS · iShares Trust	0.10%	978,878 SH	Sept. 11, 2026	Daily
EQAL · Invesco Exchange-Traded Fund Trust …	0.10%	50,803 SH	Oct. 2, 2026	Daily
WSML · iShares Trust	0.09%	41,659 SH	Sept. 11, 2026	Daily
VXF · VANGUARD INDEX FUNDS	0.08%	7,835,858 SH	Aug. 19, 2026	Daily
VB · VANGUARD INDEX FUNDS	0.08%	15,636,784 SH	Aug. 19, 2026	Daily
TILT · FlexShares Trust	0.08%	121,976 NS	July 31, 2026	N-PORT
RECS · Columbia ETF Trust I	0.08%	325,274 NS	July 31, 2026	N-PORT
IWR · iShares Trust	0.07%	2,700,866 SH	Sept. 11, 2026	Daily
IUS · Invesco Exchange-Traded Self-Indexe…	0.06%	37,709 SH	Oct. 2, 2026	Daily
PRF · Invesco Exchange-Traded Fund Trust	0.04%	251,941 SH	Oct. 2, 2026	Daily
IUSV · iShares Trust	0.03%	593,664 SH	Sept. 11, 2026	Daily
DXUV · Dimensional ETF Trust	0.03%	11,452 NS	July 31, 2026	N-PORT
IWD · iShares Trust	0.03%	1,462,438 SH	Sept. 11, 2026	Daily
VONV · VANGUARD SCOTTSDALE FUNDS	0.02%	397,791 SH	Aug. 19, 2026	Daily
IYY · iShares Trust	0.01%	29,349 SH	Sept. 11, 2026	Daily
IWB · iShares Trust	0.01%	457,613 SH	Sept. 11, 2026	Daily
ITOT · iShares Trust	0.01%	885,606 SH	Sept. 11, 2026	Daily
IWV · iShares Trust	0.01%	183,968 SH	Sept. 11, 2026	Daily
VTI · VANGUARD INDEX FUNDS	0.01%	21,681,946 SH	Aug. 19, 2026	Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0.01%	534,809 SH	Aug. 19, 2026	Daily
VONE · VANGUARD SCOTTSDALE FUNDS	0.01%	109,164 SH	Aug. 19, 2026	Daily
VTHR · VANGUARD SCOTTSDALE FUNDS	0.01%	55,632 SH	Aug. 19, 2026	Daily
ESGV · VANGUARD WORLD FUND	0.01%	149,286 SH	Aug. 19, 2026	Daily
NEAR · iShares U.S. ETF Trust	0.01%	365,000 SH	Sept. 9, 2026	Daily
DFUS · Dimensional ETF Trust	0.00%	5,257 NS	July 31, 2026	N-PORT
DFSU · Dimensional ETF Trust	0.00%	544 NS	July 31, 2026	N-PORT
DFAU · Dimensional ETF Trust	0.00%	1,476 NS	July 31, 2026	N-PORT
DFAC · Dimensional ETF Trust	0.00%	2,958 NS	July 31, 2026	N-PORT
IJH · iShares Trust	·	23,957,709 SH	Sept. 11, 2026	Daily
IJJ · iShares Trust	·	3,487,441 SH	Aug. 31, 2026	Daily
XJH · iShares Trust	·	93,400 SH	Sept. 8, 2026	Daily
ISCB · iShares Trust	·	29,420 SH	Sept. 11, 2026	Daily
ISCV · iShares Trust	·	144,718 SH	Sept. 11, 2026	Daily

AVTR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21

rating · 25 analysts HOLD

Median target $14.40 -6.1%

3 12.0% Strong Buy

5 20.0% Buy

16 64.0% Hold

1 4.0% Sell

0 0.0% Strong Sell

12-Month Price Target

15 analysts · 2026-09-28

Mean target $14.66 -4.4%

Now Current price $15.34

Low$12.00 Mean$14.66 High$19.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker	Market Cap	P/E	Rev YoY	Net Margin	ROE	Gross Margin
AVTR	$7.82B	-14.7	-3.4%	-8.1%	-8.9%	32.6%
TEM	·	-41.9	83.4%	-19.3%	-61.2%	·
TEM	·	-41.9	83.4%	-19.3%	-61.2%	·
CRL	$10.02B	-70.0	-0.85%	-3.6%	-4.4%	·
TXG	$2.08B	-46.6	5.2%	-6.8%	-5.5%	69.0%
TECH	$11.03B	60.9	-0.38%	15.0%	9.0%	65.8%
RGEN	$9.23B	190.5	16.4%	6.6%	2.4%	·
BRKR	$7.17B	-314.1	2.1%	-0.25%	-0.40%	45.9%
BIO	·	·	·	·	·	·
SHC	$5.02B	65.3	5.7%	6.7%	14.0%	55.5%
ADPT	$2.50B	-41.6	54.8%	-21.5%	-28.2%	·

Latest News Recent headlines mentioning this company

23

RBC Capital Initiates Avantor (AVTR) With Sector Perform Rating Yahoo Finance · 4 months ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

AVTR Avantor, Inc. Common Stock